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Summary 
The Staphylococcal enterotoxin superantigens  stimulate  vigorous responses in T cells bearing 
certain T cell antigen receptor (TCR) V~ regions. In addition to activation, these superantigens 
also impart negative signals to T cells resulting in a profound state of unresponsiveness or anergy. 
The Staphylococcus  aureus enterotoxins (SE) B and C2 bind to a closely related  site on major 
histocompatibility complex (MHC) human leukocyte antigen (HLA)-DK1 molecules. Only SEB, 
however, interacts with the TCR V/33 region of HA1.7, a human HLA-DK1 restricted T cell 
done specific for influenza haemagglutinin. In competition experiments, we demonstrated that 
the induction of anergy in HA1.7 by SEB is unaffected by the presence of SEC2. These results 
suggest that SEB-induced anergy is MHC independent and involves a direct interaction between 
the TCR and SEB. To resolve definitively whether SEB binds directly to T cells in the absence 
of MHC class II molecules, the cDNAs encoding the HA1.7 TCK were transfected into an MHC 
class II-negative human T cell line. The addition of SEB to these transfectants resulted in the 
downregnlation of cell surface TCK expression, an increase in the concentration of intracellular 
calcium ions, the production of lympholcines, and reduced responsiveness to a subsequent challenge 
with SEB. We conclude that SEB interacts directly with the TCR in the absence of cointeraction 
with MHC class II molecules, and that this interaction may induce anergy in HA1.7. 
group of exotoxins produced by certain strains of Staph- 
ylococcus aureus induce vigorous responses in T cells ex- 
pressing particular TCR VB elements (1-4). Such exotoxins 
have thus been termed superantigens.  In common with en- 
dogenous murine retroviral superantigens, bacterial superan- 
tigens also have the capacity to shape the TCR repertoire 
by clonal deletion (2, 5) or the induction of anergy (6-8). 
Since thymic deletion alone fails to explain self-tolerance to 
antigens expressed exclusively by adults  or in sites remote 
from the neonatal thymus, anergy, which can be induced in 
mature T cells, is proposed to account for T cell unrespon- 
siveness to these antigens both in in vivo (6-9) and in vitro 
models  (10-12). 
Incubation of human T cell clones with supraoptimal con- 
centrations of nominal peptide antigen renders the cells anergic 
to  a  subsequent  immunogenic challenge (10, 11,  13). In 
common with antigen-specific  T  cell activation,  antigen- 
induced anergy is initiated by MHC class II-restricted an- 
tigen presentation  (14). 
More recently, it has been demonstrated that Staf~lococcus 
aureus  enterotoxin (SE)  1 superantigens,  are also able to in- 
duce T  cell anergy to their native ligand (12, 15). Unlike 
peptide antigen-induced anergy, however, enterotoxin-induced 
anergy was not inhibited by anti-MHC class II mAbs (R. E. 
O'Hehir and J. K. Lamb, unpublished observations). 
The aim of the present study was, therefore, to determine 
whether a Staphylococcal enterotoxin superantigen was able 
to interact directly with the TCK and induce donal anergy 
in the absence of MHC-dependent antigen presentation. 
Materials and Methods 
Reagents and Cell Lines.  HA1.7  is a human CD4 + T cell clone 
specific  for influenza  haemagglutinin  (HA) peptide 307-319 in the 
1 Abbreviations  used in this paper: An.PCK, anchored polymerase chain re- 
action; HA, influenza  haemagglutinin;  SE, Staptu  aureus  enterote~dn. 
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B ceil line used as an APC (16). JR.T3T3.5, a CD3-TCK negative, 
MHC class R-negative mutant of  Jurkat (17), was a gift from Dr. 
A. Weiss (University  of California,  San Frandsco). CTLbM, a mu- 
rine l~2-depenckmt  T cell line used for the bioassay  of  Jurkat-derived 
supematants (18), was obtained from the European Collection of 
Animal Ceil Cultures (EACC) (Porton Down, UK). Olignnucle- 
otides were synthesized by Dr. Ian Goldsmith (Imperial Cancer 
Research Fund). The HA peptide 307-319 was synthesized  by Dr. 
J. Rothbard (ImmuLogic  Pharmaceutical  Corp.). FITC-conjugated 
goat antibodies specific  for mouse Igs and anti-CD3 were obtained 
from Becton Dickinson & Co. (Mountain View, CA). MX6, an 
anti-TCR Vfl8 mAb was obtained from Dr. S. Carrel (Ludwig In- 
stitute, Epalinges, Switzerland). SEB, SEC1, and SEC2 were ob- 
tained from Sigma Chemical Co., (Poole Dorset, UK) or Toxin 
Technology, Inc. (Madison, WI). 
Cloning of TCR ot and ~ chain eDNA.  HA1.7  was purified free 
of  APC and stimulated  for 6 h with 1/~g/ml phytohaemagglutinin-P 
(Sigma Chemical Co.) and 10 ng/ml PMA (Sigma Chemical Co.) 
to increase  TCR. rv and fl chain mtLNA expression (19). ILNA  was 
purified from 5  x  106 cells by the guanidine isothiocyanate-acid 
phenol method (20). cDNA was synthesized by a standard oligo- 
dT primed method (21). cDNAs encoding the HA1.7 TCR ~ and 
fl chains were then amplified using the anchored PCR (AnPCK) 
(22) as modified  by Dr, P. Marche  and Dr. O. ,A~-uto  (Institut Pasteur, 
Paris, France). 
For amplification of TCR c~ chain cDNA, an antisense primer 
was designed to include part of the C region (bold type  ), and 
EcotLI, and BgllI sites: 5' GCGAATTCAGATCTTAGC~AGA- 
CAGACTI~TCACTC~. 3'; the sense primer for the TCR c~ 
chain contained  a dC anchor, XhoI, NotI, and Sail sites: 5' CACIC- 
GAGCGC~CGCGTCGACCCCCCCCCC  3'.  The  antisense 
primer used to amplify the TCR fl chain contained part of the 
C region (bold type  ), KpnI, SalI, and ClaI sites: 5' GGTACC- 
GTCGACATCGATCCACCAGCI~AGC'I3CCACGTGGTCG 
3: The sense primer for the TCR/$ chain included a dC anchor, 
SphI, NotI, and SaclI sites: 5' GCATGCGCGCGC~CGCGGA- 
GGCCCCCCCCCCCCCC 3'. 25 cycles of AnPCK were per- 
formed, each cycle consisting of 1 rain at 940C, 2 rain at 550C, 
3 min at 720C, and a single final extension of 6 rain at 72~ 
AnPCK products were isolated, cloned, and sequenced by stan- 
dard methods. Full o~ and B coding sequences were constructed 
using constant region cDNAs derived  from the Jurkat TCR c~ and 
chains. 
Functional Expression of TCR.  The HA1.7 TCK ~x and/~ con- 
structs (OBod4/4 and CUBBI.5) were cloned into the eucaryotic 
expression vector PJ6f/, in which eDNA is transcribed under the 
control of the rat actin promoter (23). pJ60 expression  vectors  con- 
taining the hygromycin B (pJ6flhygro) or puromycin (pJ6flpuro) 
resistance genes, were made available by Dr. H. Land (Imperial 
Cancer Research Fund). 
The HA1.7 TCR B expression  construct (50 #g/ml) was cotrans- 
fected with pJ61l hygro (25/zg/ml) into 2  x  107 JKT3T3.5 by 
electroporation (450 V at 125/zF). Cells were immediately placed 
on ice and resuspended in KPMI 1640 containing 10% FCS. After 
3 d of culture, the medium was supphmented with 400 ttg/ml 
hygromycin-B (Sigma Chemical Co.). 
After 3 wk, the o~ chain expression construct was cotransfected 
with pJ6fl puro into the r  chain transfected line by electropora- 
tion.  Cells were selected in medium containing 400 ktg/ml of 
hygromycin-B,  and 4/zg/ml of puromycin (Sigma Chemical Co.), 
and the resulting  cell  line assessed  for CD3 expression  by flow cytom- 
eter analysis.  Cells were sorted for high CD3 expression three times 
and then cloned by limiting dilution. Clones were screened for re- 
sponses to peptide 307-319 and SEB in the presence of  LNAT APC. 
One particularly eflficient  done CH7C17 was used for the majority 
of these studies. 
A mock transfected subline designated OGSL1 was also gener- 
ated. This line underwent all the procedures outlined above, but 
was electroporated in the absence of plasmid DNA. 
Functional Assays.  Anergy was induced by incubation of T cells 
(10Vml) with HA peptide 307-319 (up to 100 #g/m1) or SEB (up 
to 100 #g/ml) for 16 h at 37~  Cells were thoroughly washed 
and then challenged with an immunogenic concentration of HA 
peptide 307-319 or SEB in the presence of irradiated (6,000 rad) 
LNAT APC. Experiments with HA1.7 were pulsed with 1/zCi 
of [3H]thymidine (Amersham International, Amersham, Bucks, 
UK) for the last 16 h of a 72-h culture. For experiments with 
CH7C17, culture supernatants  were taken at 72 h and used to stimu- 
late CTLDM ceils for 24 h. Proliferation was then measured by 
[3H]thymidine incorporation for the last 8 h of culture. 
Assay oflntracellular Calcium.  Cells  were washed three times 
with serum-free KPMI, then incubated with 1/zg/ml Fura-2 in 
KPMI at 37~  for 15 min. Ceils were washed twice with HBSS 
containing 20 mM Hepes at pH 7.3, and resuspended at l(Y/ml. 
Two ml of cells were placed in a cuvette and warmed to 37~  with 
stirring in a fluorimeter (The Perkin-Elmer Corp., Norwalk, CT) 
set to excite at 325 nm and measure fluorescence  at 510 nm. The 
stimulus was added and the fluorescence recorded for 5 rain. 
Immunofluorescence.  Cells  were stained for sorting or ceil sur- 
face phenotype analysis  by standard methods using mAb directly 
conjugated to FITC, or a primary mAb followed  by a second layer 
of FITC-conjugated goat antibodies specific for mouse Ig. 
SEB and SEC2 Competition Binding Assay.  SEB was biotiny- 
hted by incubating a twofold molar excess  of  N-hydroxysuccinimide 
active ester of long chain biotin with SEB (1 mg/ml) overnight 
at 4~  Unbound biotin was removed  by Sephadex  G-25 gd filtra- 
tion. Biotinylated SEB (50 #g/ml) was incubated with 1BW4, an 
HLA-DK1-Dwl  EBV-transformed B cell line, for 2 h at 40C in 
the presence of various concentrations of unlabeled SEB or SEC2. 
Ceils were washed with PBSA  containing 0.1% BSA and incubated 
at 40C with FITC-avidin D (Vector Labs., Inc., Burlingame, CA) 
at 10/zg/ml for 30 rain. Ceils were washed and resuspended in 
PBSA containing 0.1% BSA for flow cytometer analysis. 
Results 
SEC2 Fails to  Compete  with SEB  during the Induction of 
Anergy.  The Staphylococcal enterotoxins SEC2 and SEB are 
known to bind to the same site on MHC class II antigens 
(24).  Unlike  SEC2, however,  SEB  stimulates  T  cdls  ex- 
pressing TCK V/~3.1 elements (12). To confirm the identity 
of  the  SEB  and  SEC2 binding  sites  on  HLA-DK1,  bi- 
otinylated SEB was incubated with HLA-DK1 + B calls in 
competition with urdabded SEB and SEC2. Consistent with 
the report that the two enterotoxins bind to a dosdy related 
site on the HLA-DK1 molecule, the binding of SEB to HLA- 
DR1 + B ceils was specifically competed with both by unla- 
baled SEB and SEC2 (Fig.  I  A). 
If SEB-induced anergy occurs by a mechanism indepen- 
dent of MHC class II binding, then it should be possible 
to anergize HA1.7 with SEB after pretreatment with an excess 
of SEC2. A  100-fold molar excess of SEC2 failed to inhibit 
the induction of anergy in HA1.7 by either SEB or the HA 
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the SEB binding site on HLA- 
DR1, but fails to inhibit anergy 
induction  by SEB or HA peptide 
307-319  in  HA1.7.  (,4).  Bi- 
otinylated SEB at 50 tzg/ml was 
incubated  with  IBW4,  HLA 
-DR1-Dwl EBV-transformed B 
cells for 2 h at 4~  in the pres- 
ence of various concentrations of 
unlabeled SEB  (filled  squares) or 
SEC2 (open squares). Biotinylated 
SEB bound to the cell surface  was 
detected using FITC-conjugated 
avidin  and flow cytometer analysis. 
(/3) HA1.7  was treated  with 50 
/~g/ml of SEC2 for 1 h at 37~ 
then incubated with an anergizing 
concentration of  SEB (0.5 ~g/ml) 
or peptide 307-319 (50/xg/m_l)  for 
16 h at 37oc. Cells were washed 
and stained with mAb specific  for 
CD3  (hatched  bars)  or  CD25 
(shaded bars). 
peptide 307-319 (Fig. 1 B). The fall  in CD3 expression,  and 
rise in CD25 expression, both characteristics  of anergy (12), 
combined with the failure of HA1.7 to incorporate thymi- 
dine after a subsequent immunogenic  challenge with HA pep- 
tide 307-319 and APC (data not shown), suggested that anergy 
induction by SEB may not require MHC class II molecules. 
Generation of MHC Class II Antigen-negative  T  Cells Ex- 
pressing the HA1.7 TCR.  The TCR ot and B chain cDNAs 
encoding the HA1.7 TCR were cloned from HA1.7 RNA 
using AnPCR. 20 clones containing a PCR fragment of the 
correct size for TCR ot were sequenced.  All 20 clones con- 
sisted of an identical sequence with no evidence for a second 
TCR ot transcript. The HA1.7 Vot region differed from the 
Votl.2 subfamily sequence by a single, conservative  base change 
a  HAl .7 TcR c~ 
Vctl.2  ~  N  ~  J  ctM 
GCT GTG AG'I'GAG TCT CCA ~  GGA AAT GAG 
A  V  S  E  S  P  F  G  N  E 
AAA TTA ACC TTT GGG ACT GGA ACA AGA CTC 
K  L  T  F  G  T  G  T  R  L 
rA~cc  c~  ACC ATC A"  C  AAT ATC 
T  1  I  P  N  I 
b  HAl.7  TcRI] 
TGT GCC AGC AGT TCG ACA~GGG TTG CCc2'I AT 
C  A  S  S  S  T  G  L  P  Y 
GGC TAC ACC TTC GGT TCG GGG ACC AGG TTA 
G  Y  T  F  G  S  G  T  R  L 
J~l.2  ~  C~ 
ACC G'I~ GTA GAGIGAC CTG AAC 
T  V  V  E  D  L  N 
Figure 2.  Sequence of HA1.7 TCR a  and ~ chain V-N-(D)-J-C junc- 
tional regions. (a) TCIL ot chain. (b) TCtL ~ chain. These sequence data 
are available  from EMBL/Genbank/DDBJ under accession  numbers X63455 
(HA1.7 TCP, alpha chain) and X63456  (HA1.7 TCR beta chain). 
(25). The N region consisted of twelve nucleotides, and was 
unique to HA1.7 (Fig. 2 A). The core sequence of the HA1.7 
Jot region was identical to that used by clone AA13 (26), 
and was most similar, but not identical, to a member of the 
M Jot family (27). 
20 dones of the single TCR B chain PCR fragment were 
also sequenced.  All 20 clones consisted of a V153.1 region 
identical to that used by the clone PL4.4 (28), a unique 9-bp 
N region, and a D/~ region with the conserved core sequence 
Gly, Leu, Pro (Fig. 2 B). The J region was identical to the 
J~1.2 region used by the cell line JM  (29). 
Full-length coding sequences of the TCR cz and B chains 
were constructed by ligation with the TCR ot and/3 con- 
stant regions of  Jurkat. Constructs were sequenced to ensure 
the correct joining of the constant regions. Each TCR eDNA 
was recloned into expression vectors and transfected into the 
CD3-TCR negative, MHC class II-negative mutant T  cell 
line JRT3T3.5. The transfected line was cloned by limiting 
dilution, and the clone CH7C17 was characterized  further. 
A  mock transfected  line OGSL1  was also characterized  in 
parallel. 
The mock transfected subline OGSL1 and the HA1.7 trans- 
fectant CH7C17 were examined for surface  expression of CD3, 
TCIL-ot/I~  and TCR V~8 by immunofluorescence. OGSL1 
was completely CD3,  TCR-od/3,  and V~8  negative, and 
CH7C17 expressed high levels of CD3 and the TCR-c~//g 
but no TCR VB8, demonstrating that the TCR expressed 
by CH7C17 was not derived from the native TCR V/38 posi- 
tive Jurkat cell line (data not shown). CH7C17 was also as- 
sayed for the expression of MHC antigens. Immunofluores- 
cence analysis using mAbs, specific  for monomorphic  epitopes 
of HLA-DR antigens, HLA-DP antigens, all MHC class II 
antigens (including HLA-DQ), and all HLA class I antigens 
showed that both the native Jurkat cell line,  OGSL1, and 
CH7C17 expressed no detectable MHC class II antigens (Fig. 
3). All cell lines however, were strongly positive for MHC 
class I antigens (data not shown; Fig.  4 A). This confirms 
results from independent laboratories which demonstrate the 
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Log Fluorescence  l  Log Fluorescence  I 
Figure 3.  Jurkat transfectants fail to express surface MHC class II an- 
tigens. CH7C17 (solid line) and LNAT (dotted line) were stained with (,4) 
goat  anti-mouse Igs  conjugated  with  FITC (GaMFITC);  (/3) FITC- 
conjugated anti-HLA-DR (Becton Dickinson & Co., Mountain  View, CA); 
(C) anti-HLA-DP (B7/21/2) and GaMFITC and (D) anti-HLA-DQ + 
DR  +  DP (CA2.11)  +  GaMFITC,  then analyzed by flow cytometry. 
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Figure  4.  Reconstitution  of  ~ so 
HA1.7 TCK antigen-MHC spec-  v 
ificity. JRT3T3.5 was transfected  ~  4o 
by dectroporation with cDNAs  '~ 
encoding the TCR a and/5 chain  7_=  ~o 
of HA1.7.  Transfected cells were 
cloned (CH7C17)  and stimulated  ~  20 
with  LNAT APC  and  peptide 
307-319  (filled  squares)  or  SEB  ~  zo 
(filled triangles).  T cell activation 
was assessed by lymphokine pro- 
duction. 
B 
complete absence of both cell surface MHC class II antigens  ] 
on various sublines ofJurkat, (S. Marsh and J. Bodmer, per-  ~ 
sonal communication), and mRNA for HLA-DP, D0o and  - i 
DR (45).._-'~  -" 
E  Unequivocal evidence that the ~CK expressed  by CH7C17  ~.. 
was identical to that expressed by HA1.7,  was obtained by 
functional analysis. CH7C17 and OGSL1 were challenged 
with various concentrations of HA peptide 307-319 and SEB 
in the presence of LNAT APC. After 24 h of culture, super- 
natants were assayed for lymphokine content in a CTLbM 
bioassay. 
As shown in Fig. 4, CH7C17 responded to both HA pep- 
tide 307-319 and SEB with a concentration-dependent re- 
sponse, demonstrating that the specificity  of  the HA1.7 TCR 
had been reconstituted in CH7C17.  The mock transfected 
cell line, OGSL1, was completely unresponsive to HA pep- 
tide 307-319 and SEB presented by LNAT APC. Neither of 
the cell lines responded  to SEC1 (data not shown). 
MHC  Class II  Independent  SEB-mediated  Signaling  in 
CH7C17,  CH7C17 was incubated in the complete absence 
of MHC class II-positive APC with SEB at concentrations 
up  to  100/~g/ml.  After overnight incubation,  cells were 
washed and assessed for the level of CD3 expression. The 
culture supernatants  were taken for lymphokine assay. 
The level of cell surface CD3 on CH7C17 cells decreased 
in an SEB concentration-dependent manner, such that higher 
concentrations  of SEB resulted in lower cell surface expres- 
sion of CD3 (Fig. 5 A). In contrast to CD3,  the level of 
MHC class I antigen expression was increased with the con- 
centration of SEB (Fig. 5 A). MHC class II expression, how- 
ever, was  not induced after  incubation with SEB. Using 
CA2.11, a mAb specific  for HLA-DR + DP + DQ antigens, 
no change was observed in the mean fluorescence intensity 
of CH7C17 after incubation in medium alone, or in the pres- 
ence of SEB. A mean fluorescence intensity of 3.4 was ob- 
served with CA2.11 and secondary antibody in both the pres- 
ence and absence of 20/~g/ml SEB. Downregulation of CD3 
was specifically due to SEB as SEA, SEC1, SEC2, and SEE 
failed to induce any change in CD3  expression (data not 
shown). Lymphokine production by CH7C17 cells also in-  : 
creased with the concentration of SEB. This increase was not 
due to the direct interaction of SEB with the CTLL-M cells 
(Pig. 5 B). 
CH7C17 Preincubated with SEB in the Absence of  MHC Class 
II Antigens Fails to Respond to a Subsequent Iramunogenic Chal- 
lenge with SER  CH7C17 was incubated without MHC class 
I(NH)" 
HN)" 
I0 
-4/  . 
.,  i  fo  1oo 
SEB  preincubaflon.  Ipg/mll. 
140 
120 
so  ~ 
0  .01  .l  I  10  100 
SEB  (FIR/roll 
Figure 5.  SEB induces down- 
regulation of CD3, and stimulates 
lymphokine production by CH7- 
C17 in the absence of MHC class 
II antigens (.4) CH7C17 was in- 
cubated for 16 h with various con- 
centrations of SEB in the absence 
of APC, cells were washed and 
stained  with  anti-CD3  (filled 
squares,  left hand  scale) or anti- 
MHC class I (filled triangles, right 
hand scale) and analyzed by flow 
cytometry.  CH7C17 was stimu- 
lated for 16 h with various con- 
centrations  of SEB in the absence 
of APC (filled squares); superna- 
tants were taken and assayed for 
lymphokines.  Various concentra- 
tions of SEB (filled triangles) were 
incubated for 16 h in the absence 
of cells. Supernatants  were then 
tested for the direct activation of 
CTLbM cells. 
II-positive APC with SEB at various concentrations  up to 
100/~g/ml. After overnight incubation,  cells were washed 
and loaded with Fura-2 for assay of changes in intracellular 
calcium ion concentration. Fura-2-1oaded cells were then 
stimulated with SEB (15/~g/ml) in the absence of APC in 
stirred cultures. Changes in intracellular calcium ion concen- 
tration upon stimulation were measured using a fluorimeter. 
Within 10 s of restimulation with SEB, the concentration 
of intracellular calcium increased, peaking at a level depen- 
dent upon the concentration of SEB used in the overnight 
incubation,  such that preincubation  with higher concentra- 
tions of SEB rendered CH7C17 less responsive to the subse- 
quent exposure (Fig. 6). This effect was specific to SEB, as 
cells incubated  overnight with  various  concentrations  of 
SEC1 (which does not activate HA1.7) had no effect on the 
increase in intraceUular calcium ions stimulated by 15 #g/ml 
SEB. Neither SEB nor SEC1 was able to increase intracel- 
lular calcium above basal levels in the TCR-negative cell line 
OGSL1 (data not shown). 
1000 
d 
IO0- 
'  . l  i  I 'o  1 6 o 
SFB  or  SECI  preincubalion  (pg/ml) 
Figure  6.  SEB  induces  un- 
responsiveness in CH7C17 cells. 
CH7C17 was incubated  for 16 h 
with  various  concentrations  of 
SEB (filled squares) or SEC1 (filled 
triangles). Cells were washed and 
loaded with Fura-2, then stimu- 
lated in the absence of APC with 
15  /~g/ml  of SEB. Changes  in 
fluorescence  induced by an increase 
in intracelhlar calcium ion con- 
centration were measured, and the 
concentration  ofintracelhlar cal- 
cium calculated. 
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This study demonstrates that a TCK of defined antigen 
specificity is able to interact with SEB in the absence of MHC 
class II antigens. Furthermore, the direct interaction of SEB 
with the TCK was able to stimulate a program of events 
leading to donal anergy in the T  cell done HA1.7. 
Characteristically, superantigens are able to bind to all TCRs 
using particular VI3 regions irrespective of the antigen-MHC 
specificity of the TCR (3). This implies that the superan- 
tigen binding region shared by certain TCK V~ regions is 
remote from the CDKs involved in MHC-restricted peptide- 
antigen recognition. In support of this, two recent studies 
have analyzed the reactivity of TCK mutants and dose V~ 
family members with different reactivities, and predicted that 
superantigen binding sites lie on the side of the TCR mole- 
cule, away from the peptide antigen-MHC binding site (30, 
31). Similar  studies on the MHC requirement of superan- 
tigen recognition have shown that many MHC class II an- 
tigen isoforms are able to present a particular superantigen 
to TCK. This suggests that superantigens bind to common 
sites on MHC class II antigens remote from the peptide an- 
tigen binding groove. 
The present results demonstrating anergy induction by pep- 
tide 307-319 in the presence of SECz (Fig. 1 B) support this 
conclusion. Others have characterized this binding site using 
cell lines that express MHC molecules with mutations in the 
peptide antigen binding groove (32),  or by demonstrating 
the binding of hbded superantigens to structurally similar 
MHC class II molecules (33). 
In a recent study of donal T  cell anergy in HA1.7, we 
demonstrated that human T cells of defined antigen-MHC 
specificity, when exposed to high concentration of SEB, Be- 
come anergic to a subsequent immtmogenic stimulus with 
their natural peptide ligand and APC (12). The present re- 
port demonstrates that, in contrast to peptide-mediated anergy, 
SEB-induced anergy in HA1.7 is not MHC dependent. Thus, 
pretreatment of HA1.7 with anti-MHC class II mAb or 
SECz, which binds to an identical site on HLA-DK1, but 
fails to interact with the HA1.7 TCK, is unable to inhibit 
SEB-induced anergy. 
To demonstrate directly that SEB interacts with the TCR 
in the absence of MHC antigens, cDNAs encoding the HA1.7 
TCK were introduced into a T  cell tumor line which ex- 
pressed no cell surface TCK and MHC class II. Incubation 
of these cells with SEB in the absence of APC resulted in 
SEB concentration-dependent T cell activation, as measured 
by a rapid increase in the concentration of intracellnlar cal- 
alum ions and lymphokine production. In common with 
HA1.7, incubation of CH7C17 with SEB in the absence of 
APC reduced cell surface CD3 expression in a dose-dependent 
manner. This downregnlation was of functional significance, 
as the cells mounted a reduced Ca  z+  response to a subse- 
quent exposure to an optimal concentration of SEB. Studies 
in vivo (34) support the conclusion that the level of TCK- 
CD3 expression is of fundamental importance in the mecha- 
nism of both T  cell activation and anergy. 
The absence of cell surface MHC class II expression by 
the transfected mutant cell line derived from  Jurkat is of central 
importance to this study. In addition to immunofluorescence 
results reported here, (Fig. 3), and those by independent groups 
(S. Marsh and J. Bodmer, personal communication) analysis 
of mRNA specific for HLA-DP, DQ, and DR has determined 
that the parental cell line of CH7C17, Jurkat, does not pro- 
duce mRNA for HLA-DP, DOo or DK (45). Furthermore, 
J. D. Fraser (35),  reports that SEA and SEB are unable to 
bind to the surface of  Jurkat cells, confirming that these ceUs 
are MHC class II negative. The complete MHC class II nega- 
tivity of  Jurkat was also shown functionally by demonstrating 
the inability of Jurkat cells to present enterotoxins to un- 
primed human PBLs (35). 
There is a single report that small amounts of MHC class 
I H chain can be immunoprecipitated  from MHC class II-posi- 
tire ceUs pulsed with enterotoxin. This study concludes that 
a small amount of class I H chain might interact with preex- 
isting enterotoxin-MHC class II complexes (35). There is no 
evidence, however, that MHC class I antigens are able to bind 
directly to, or present enterotoxins to T cells (36). Indeed, 
even CD8 positive, class I-restricted CTL TCKs interact 
with SE only when bound to MHC class II (37). We there- 
fore conclude that SEB-induced dowuregulation of CD3 in 
CH7C17 and anergy in HA1.7 is MHC independent and in- 
voices a direct interaction between the TCK and SEB. 
Other groups have also obtained circumstantial evidence 
that superantigens might bind directly to the TCR (37--40). 
Immobilized or cross-linked Streptococcal M toxin has been 
shown to stimulate native Jurkat cells to produce IL-2 (41). 
T cells may also be stimulated in the absence of APC by con- 
jugation ofa T cell-surface antigen-specific mAb to the same 
solid support as an enterotoxin (42). There is also a report 
that enterotoxins may behave in a similar manner to soluble 
anti-CD3 mAb in their ability to induce early activation events 
in T  cells (38). 
The ability to anergize T cells in the absence of MHC class 
II antigens using enterotoxins has clinical implications in, 
for example, autoimmune and allergic diseases, where there 
may be restricted TCR V/3 usage in the harmful T cell re- 
sponses, but where the antigen is either not determined or 
extremely complex, and involvement of MHC antigens is 
ill-defined. In these cases, enterotoxins modified to separate 
the enterotoxic (emetic) from TCR binding activity (43), 
and possibly the TCK from MHC binding activity (44), could 
be used to anergize T cells expressing particular V/~ regions 
implicated in disease processes. 
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